G4M-55143-29578
2 vaccinations
6 coded responses
17 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 335 / FL
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Good · Site: Redness, Itching · Rash, not including the immediate area around the injection siteFree text: Itching always includes entire circumference of my upper arm not just at siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
- 2021-01-15
-
2021-01-24
Survey response — day 14, dose 1MedDRA: Asthma — Feeling: GoodFree text: Asthma exacerbationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discolouration — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: I still have persistent discoloration over the site of dose 1MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-02-13
Survey response — day 14, dose 2MedDRA: Hypotension, Injection site discolouration, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Discoloration still at 1st dose site unchanged, larger at dose 2 site. Blood pressure has been lower than usual but not dangerously low or symptomatic. · Healthcare visit (other): Routine cardiologist follow upMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-13
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-20
Survey response — day 21, dose 2MedDRA: Dizziness — Feeling: FairFree text: Dizzy spellsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-01
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-30
- 2021-07-31
-
2022-01-30
Survey response — 12 months, dose 2MedDRA: Abdominal discomfort, Abdominal pain, Diarrhoea, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had about 4-5 days of GI upset that started with vomiting and followed with diarrhea and abdominal pain.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Itching always includes entire circumference of my upper arm not just at site
Release 2 — day 14, dose 1
Symptoms: Asthma exacerbation
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): I still have persistent discoloration over the site of dose 1
Release 4 — day 14, dose 2
Symptoms: Discoloration still at 1st dose site unchanged, larger at dose 2 site. Blood pressure has been lower than usual but not dangerously low or symptomatic.
Healthcare visit (other): Routine cardiologist follow up
Release 4 — day 21, dose 2
Symptoms: Dizzy spells
Release 11 — 12 months, dose 2
Symptoms: I had about 4-5 days of GI upset that started with vomiting and followed with diarrhea and abdominal pain.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Abdominal pain | · | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Hypotension | ✓ | ✓ | ✓ |
| SD | Injection site discolouration | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Injection site discolouration | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release